Effects of cisplatin on matrix metalloproteinase-2 in transformed thyroid cells

Biochemical Pharmacology

Volumn 79, Issue 6, 2010, Pages 810-816

  Urso, L ^a   Muscella, A ^a   Calabriso, N ^a   Vetrugno, C ^a   Jimenez E ^b   Montiel, M ^b   Marsigliante, S ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

AKT PKB; Cisplatin; ERK1 2; MMP 2; PC E1Araf; PKC

Indexed keywords

CISPLATIN; GELATINASE A; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C ZETA; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME RELEASE; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; THYROID CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TRANSFORMED; CISPLATIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; MATRIX METALLOPROTEINASE 2; RATS; RNA, SMALL INTERFERING; THYROID GLAND;

EID: 74149089295     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.10.013     Document Type: Article

References (32)

1. Sasanelli R., Boccarelli A., Giordano D., Laforgia M., Natile G., Cardellicchio C., et al. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of MMP-2, -3, -9, and -12. J Med Chem 50 (2007) 3434-3441
2. Mignatti P., and Rifkin D.B. Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res 78 (2000) 103-157
3. Chintala S.K., Ali-Osman F., Mohanam S., Rayford A., Go Y., Gagercas E., et al. Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro. Clin Exp Metastasis 15 (1997) 361-367
4. Mabuchi S., Ohmichi M., Nishio Y., Kimura A., Ohta T., Saito M., et al. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279 (2004) 23477-23485
5. Morikawa T., Shibuya M., Sakai S., and Kudo S. Effect of anticancer drugs on invasive capacity of human small-cell lung cancer cells in vitro. Nippon Ika Daigaku Zasshi 64 (1995) 320-328
6. Arai K., Lee S.R., and Lo H. Essential role for ERK Mitogen-activated protein kinase in matrix metalloprotease-9 regulation in rat cortical astocytes. Glia 43 (2003) 254-264
7. Mendes O., Kim H.T., Lungu G., and Stoica G. MMP-2 role in breast cancer brain metastasis development and its regulation by TIMP 2 and ERK1/2. Clin Exp Metastasis 24 (2007) 341-351
8. Nakamura H., Ueno H., Yamashita K., Shimada T., Yamamoto E., Fujimoto N., et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59 (1999) 467-473
9. Muscella A., Urso L., Calabriso N., Vetrugno C., Fanizzi F.P., Storelli C., et al. Functions of epidermal growth factor receptor in cisplatin response of thyroid cells. Biochem Pharmacol 77 (2009) 979-992
10. Berlingieri M.T., Santoro M., Battaglia C., Grieco M., and Fusco A. The Adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes. Oncogene 8 (1993) 249-255
11. Fusco A., Berlingieri M.T., Di Fiore P.P., Portella G., Grieco M., and Vecchio G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7 (1987) 3365-3370
12. Urso L., Muscella A., Calabriso N., Ciccarese A., Fanizzi F.P., Storelli C., et al. Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. Biochem Biophys Res Commun 337 (2005) 297-305
13. Muscella A., Marsigliante S., Verri T., Urso L., Dimitri C., Bottà G., et al. PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. J Cell Physiol 217 (2008) 103-112
14. Montiel M., Pérez de la Blanca E., and Jiménez E. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem Biophys Res Commun 327 (2005) 971-978
15. Katome T., Obata T., Matsushima R., Masuyama N., Cantley L.C., Gotoh Y., et al. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278 (2003) 28312-28323
16. Muscella A., Urso L., Calabriso N., Ciccarese A., Migoni D., Fanizzi F.P., et al. Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment. Biochem Pharmacol 71 (2005) 50-60
17. Muscella A., Calabriso N., Fanizzi F.P., De Pascali S.A., Urso L., et al. [Pt(O,O′-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway. Br J Pharmacol 153 (2008) 34-49
18. Muscella A., Calabriso N., De Pascali S.A., Urso L., Ciccarese A., Fanizzi F.P., et al. New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. Biochem Pharmacol 74 (2007) 28-40
19. Lukashev M.E., and Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8 (1998) 437-441
20. Fini M.E., Cook J.R., and Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 90 (1998) S12-S23
21. Hanemaaijer R., Verheijen J.H., Maguire T.M., Visser H., McDermott E., O'Higgins N., et al. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 86 (2000) 204-207
22. Tanimura S., Asato K., Fujishiro S.H., and Kohno M. Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem Biophys Res Commun 304 (2003) 801-806
23. Liu J.F., Crépin M., Liu J.M., and Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 93 (2002) 1174-1182
24. Pan M.R., and Hung W.C. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem 277 (2002) 32775-32780
25. Utani A., Momota Y., Endo H., Kasuya Y., Beck K., Nomizu M., et al. Laminin alpha 3 LG4 module induces matrix metalloproteinase-1 through mitogen-activated protein kinase signaling. J Biol Chem 278 (2003) 34483-34490
26. Esparza J., Vilardell C., Calvo J., Juan M., Vives J., Yagüe J., et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94 (1999) 2754-2766
27. Martiny-Baron G., Kazanietz M.G., Mischak H., Hug H., Marme D., and Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö6976. J Biol Chem 268 (1993) 9194-9197
28. Sariahmetoglu M., Crawford B.D., Sawicka J., Li L., Holmes C., Berthiaume L.G., et al. Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J 21 (2007) 2486-2495
29. Xie Z., Singh M., Siwik D.A., Joyner W.L., and Singh K. Osteopontin inhibits interleukin-1 beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta. J Biol Chem 278 (2003) 48546-48552
30. Lefranc F., Brotchi J., and Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23 (2005) 2411-2422
31. Lucchesi P.A., Sabri A., Belmadani S., and Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110 (2004) 3587-3593
32. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839